Back to today’s briefing

Story perspectives

Breakthroughs in Pancreatic Cancer Treatment Offer New Hope

3/1/2025

37 5

Summary

Story summary

Exciting breakthroughs in pancreatic cancer treatment are on the horizon! The innovative H101 oncolytic virus, paired with irreversible electroporation, has shown remarkable ability to halt tumor growth by activating the JNK-MAPK pathway. Meanwhile, the immune-boosting CAN-2409 therapy has extended median survival to an impressive 31.4 months, paving the way for larger trials. Hope is rising for patients!

1 of 1

Story summary

Exciting breakthroughs in pancreatic cancer treatment are on the horizon! The innovative H101 oncolytic virus, paired with irreversible electroporation, has shown remarkable ability to halt tumor growth by activating the JNK-MAPK pathway. Meanwhile, the immune-boosting CAN-2409 therapy has extended median survival to an impressive 31.4 months, paving the way for larger trials. Hope is rising for patients!